Navigating Regulatory Hurdles in Drug Development
DrugBank
JUNE 18, 2025
In 2020, the FDA halted Johnson & Johnson’s COVID-19 vaccine production at a contract manufacturing facility after discovering quality control issues. One notable success story is Moderna’s mRNA vaccine development for COVID-19, which benefited from early regulatory engagement and streamlined approval pathways.
Let's personalize your content